Cargando…
Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong
BACKGROUND AND OBJECTIVES: Type 2 diabetes mellitus (T2DM) patients with Coronavirus Disease 2019 (COVID-19) have poorer prognosis. Inconclusive evidence suggested dipeptidyl peptidase-4 inhibitors (DPP4i) might reduce inflammation and prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co...
Autores principales: | Wong, Carlos K.H., Lui, David T.W., Lui, Angel Y.C., Kwok, Ashley C.Y., Low, Marshall C.H., Lau, Kristy T.K., Au, Ivan C.H., Xiong, Xi, Chung, Matthew S.H., Lau, Eric H.Y., Cowling, Benjamin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632053/ https://www.ncbi.nlm.nih.gov/pubmed/34863934 http://dx.doi.org/10.1016/j.diabet.2021.101307 |
Ejemplares similares
-
Metformin Use in Relation to Clinical Outcomes and Hyperinflammatory Syndrome Among COVID-19 Patients With Type 2 Diabetes: A Propensity Score Analysis of a Territory-Wide Cohort
por: Wong, Carlos K. H., et al.
Publicado: (2022) -
Biliary Atresia – emerging diagnostic and therapy opportunities()
por: Lendahl, Urban, et al.
Publicado: (2021) -
Impact of COVID-19 on seizure-related emergency attendances and hospital admissions — A territory-wide observational study()()()
por: Leung, William C.Y., et al.
Publicado: (2021) -
Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study
por: Wong, Carlos K. H., et al.
Publicado: (2022) -
Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong
por: Lui, David T. W., et al.
Publicado: (2023)